GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1601 - 1625** of **4050** in total

« First

‹ Prev

…

61

62

63

64

65

66

67

68

69

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 2	15	mild	G32611KT	30
IgG	Patient 2	24	mild	G32611KT	30
IgM	Patient 2	15	mild	G32611KT	94
IgM	Patient 2	24	mild	G32611KT	64
IgM	Patient 1	6	moderate	G32611KT	33
IgA	Patient 2	3	mild	G32611KT	275
IgG	Patient 2	3	mild	G32611KT	29
IgM	Patient 2	3	mild	G32611KT	67
IgA	Patient 3	-180	mild	G32611KT	285
IgA	Patient 3	11	mild	G32611KT	372
IgG	Patient 3	-180	mild	G32611KT	75
IgM	Patient 3	-180	mild	G32611KT	148
IgA	Patient 3	4	mild	G32611KT	319
IgG	Patient 3	11	mild	G32611KT	38
IgG	Patient 3	4	mild	G32611KT	34
IgM	Patient 3	11	mild	G32611KT	97
IgM	Patient 3	4	mild	G32611KT	84
IgA	Patient 4	12	mild	G32611KT	327
IgG	Patient 4	12	mild	G32611KT	75
IgM	Patient 4	12	mild	G32611KT	139
IgA	Patient 1	10	moderate	G32699RJ	380
IgA	Patient 1	22	moderate	G32699RJ	355
IgA	Patient 1	6	moderate	G32699RJ	405
IgG	Patient 1	10	moderate	G32699RJ	22
IgG	Patient 1	22	moderate	G32699RJ	28